Drug Pricing Strategies To Be Discussed At HHS Drug Conference In August
Executive Summary
The pharmaceutical industry's methods for arriving at drug prices will be considered at an HHS conference in August.
You may also be interested in...
RxHealth Value Will Participate In HHS Pricing Conference; PhRMA Declines
RxHealth Value Executive Director John Golenski, PhD, will be among participants in the Aug. 8-9 HHS pharmaceutical pricing conference.
RxHealth Value Will Participate In HHS Pricing Conference; PhRMA Declines
RxHealth Value Executive Director John Golenski, PhD, will be among participants in the Aug. 8-9 HHS pharmaceutical pricing conference.
Comparative Trials Urged By NEJM Departing Editor To Deter "Me-Too" Drugs
FDA should make new drug approvals based on comparisons to existing therapies in order to stem the tide of "me-too" medications being brought to market, New England Journal of Medicine Editor-In-Chief Marcia Angell, MD, said in the journal's June 22 issue.